1. Vaccination against tumour blood vessels in colorectal cancer
   H.J.M. Ferguson et al, 2014, European Journal of Surgical Oncology (EJSO) CrossRef
2. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
   Yingting Xu et al, 2023, European Journal of Medical Research CrossRef
3. Potential association factors for developing effective peptide-based cancer vaccines
   Chongming Jiang et al, 2022, Frontiers in Immunology CrossRef
4. A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors
   Yasuki Hijikata et al, 2018, PLOS ONE CrossRef
5. RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer
   Norimasa Matsushita et al, 2017, Oncology Letters CrossRef
6. Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
   Ryuji Okuyama et al, 2013, OncoImmunology CrossRef
7. Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity
   Jie Zhang et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
8. Trial Watch
   Fernando Aranda et al, 2013, OncoImmunology CrossRef
9. Novel avenues in immunotherapies for colorectal cancer
   Iris N. Pardieck et al, 2016, Expert Review of Gastroenterology & Hepatology CrossRef
10. Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
    Koichi Shimizu et al, 2014, Human Vaccines & Immunotherapeutics CrossRef
11. Phase 1 study of OCV‐C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer
    Hiroya Taniguchi et al, 2017, Cancer Science CrossRef
12. TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer
    Zhigui Li et al, 2023, Frontiers in Oncology CrossRef
13. Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
    Atsushi Aruga, 2013, OncoImmunology CrossRef
14. Application of VEGF/VEGFR peptide vaccines in cancer: A systematic review of clinical trials
    Fatemeh Zahedipour et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
15. An idiosyncratic and imperative laconic view on peptide-based vaccines
    Prabhjot Singh et al, 2023, INTERNATIONAL CONFERENCE ON HUMANS AND TECHNOLOGY: A HOLISTIC AND SYMBIOTIC APPROACH TO SUSTAINABLE DEVELOPMENT: ICHT 2022 CrossRef
16. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage
    Petr Muller et al, 2019, Journal of Ovarian Research CrossRef
17. Tumor vaccines: Toward multidimensional anti-tumor therapies
    Yuanfang Tan et al, 2023, Human Vaccines & Immunotherapeutics CrossRef